4//SEC Filing
Nichols Weston 4
Accession 0000902664-25-002511
CIK 0001783328other
Filed
May 20, 8:00 PM ET
Accepted
May 21, 4:49 PM ET
Size
8.9 KB
Accession
0000902664-25-002511
Insider Transaction Report
Form 4
Lynx1 Capital Management LP
10% Owner
Transactions
- Purchase
Common Stock
2025-05-20$1.20/sh+1,200,000$1,440,000→ 7,946,141 total(indirect: See footnote) - Purchase
Common stock, $0.0001 par value per share ("Common Stock")
2025-05-19$1.20/sh+1,388,794$1,666,553→ 6,746,141 total(indirect: See footnote)
Nichols Weston
10% Owner
Transactions
- Purchase
Common stock, $0.0001 par value per share ("Common Stock")
2025-05-19$1.20/sh+1,388,794$1,666,553→ 6,746,141 total(indirect: See footnote) - Purchase
Common Stock
2025-05-20$1.20/sh+1,200,000$1,440,000→ 7,946,141 total(indirect: See footnote)
Footnotes (1)
- [F1]The securities to which this filing relates are held directly by Lynx1 Master Fund LP and a managed account to which Lynx1 Capital Management LP (the "Investment Manager") serves as investment manager. Weston Nichols ("Mr. Nichols") is the sole member of Lynx1 Capital Management GP LLC, the general partner of the Investment Manager. Each of the Investment Manager and Mr. Nichols disclaims beneficial ownership of the securities to which this filing relates for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except to the extent of his or its pecuniary interest therein, if any.
Documents
Issuer
TScan Therapeutics, Inc.
CIK 0001783328
Entity typeother
Related Parties
1- filerCIK 0001746376
Filing Metadata
- Form type
- 4
- Filed
- May 20, 8:00 PM ET
- Accepted
- May 21, 4:49 PM ET
- Size
- 8.9 KB